Capstone Investment Advisors’s EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share EQHA.WS Stock Holding History
Bought
Maintained
Sold
Other funds holding EQHA.WS
RCM
MP
LP
SCM
BFM
SCM
PC
MF
AC
MC
Capstone Investment Advisors's EQHA.WS Position: Q3 2022 in Review
Capstone Investment Advisors sold out of EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share (EQHA.WS) in Q3 2022, closing a stake of 35,150 shares — an estimated $3K sold.
Capstone Investment Advisors first reported a position in EQHA.WS in Q1 2021 and held it in 6 quarters. The position peaked at $25K in Q2 2021. 63 funds tracked by Wall St. Rank hold EQHA.WS as of Q3 2022.
- Capstone Investment Advisors reported no remaining EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share position as of Q3 2022 after selling out during the quarter.
- Capstone Investment Advisors sold 35,150 EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share shares in Q3 2022, an estimated $3K.
- Capstone Investment Advisors first reported a position in EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share in Q1 2021 and held it in 6 quarters.
- Capstone Investment Advisors's EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share position peaked at $25K in Q2 2021.
- 63 funds tracked by Wall St. Rank held EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share as of Q3 2022.
Based on Capstone Investment Advisors's 13F filing for Q3 2022, filed 10 Nov 2022.